Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Single Center, Investigator-initiated Clinical Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Subjects With Mild to Moderate Seborrheic Dermatitis of the Face

NCT02749383 is registered in ClinicalTrials.gov with Amorepacific Corporation as lead sponsor.

NCT NCT02749383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02749383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Single Center, Investigator-initiated Clinical Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Subjects With Mild to Moderate Seborrheic Dermatitis of the Face
Lead sponsor
Amorepacific Corporation
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2014
Completion date
October 31, 2015
Enrollment
75 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

seborrheic dermatitis